首页> 外文会议>Bioinformatics and Biomedicine, 2009. BIBM '09 >Multiagent Approach for Identifying Cancer Biomarkers
【24h】

Multiagent Approach for Identifying Cancer Biomarkers

机译:鉴定癌症生物标志物的多试剂方法

获取原文

摘要

This paper addresses an important and vital problem within the general area of disease recognition, namely identifying disease biomarker genes. Given the complexity of this domain, the basic idea tacked in this paper is employing multiple agents to handle this problem. Though the developed methodology is general enough to be applied to any other domain, we concentrate on identifying cancer biomarkers in this paper. Our approach is mainly based on detecting the minimum set of genes that could successfully identify cancer samples. Multiple agents are involved in the process. After each agents applies its own rules and reports candidate cancer biomarkers, the agents negotiate to agree on the actual biomarkers. The latter process may require further investigation of the characteristics of each of the reported genes because some of them may have the same functionality and the target is a compromise of the best representative of each functionality. A degree of confidence in each candidate biomarker influences the negotiation process. The so far conducted experiments reported very encouraging results with high classification rate; none of the involved agents could alone achieve a close success~rate.
机译:本文解决了疾病识别的一般领域中的一个重要且至关重要的问题,即识别疾病生物标记基因。考虑到该域的复杂性,本文提出的基本思想是使用多个代理来解决此问题。尽管已开发的方法足够通用,可应用于任何其他领域,但我们还是在本文中着重于识别癌症生物标志物。我们的方法主要基于检测可以成功识别癌症样本的最小基因集。该过程涉及多个代理。在每个代理商应用自己的规则并报告候选癌症生物标记后,代理商协商就实际的生物标记达成一致。后一个过程可能需要进一步研究每个报告基因的特征,因为其中一些可能具有相同的功能,而目标是每个功能的最佳代表的折衷。每个候选生物标志物的置信度都会影响协商过程。迄今为止进行的实验报告了非常令人鼓舞的结果,具有很高的分类率。所涉及的代理商没有一个能单独取得成功。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号